Ledger.Open graph →
SEC Form D · Amendment · filed June 15, 2022

Artizan Biosciences, Inc

Offering
$18.9M
Sold
$18.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Paul R. Gross · Columbus, OHDirectorChristy A. Shaffer · Chapel Hill, NCDirectorJames W. Collins, Jr · San Antonio, TXDirectorBridget A. Martell · New Haven, CTExec · DirectorBridget A. Martell · New Haven, CTExec · DirectorBrian Barnes · Chicago, ILDirectorKristor Gervat · New York, NYDirectorSt. John D. Mcgrath · New Haven, CTDirectorSt. John D. Mcgrath · New Haven, CTDirectorE. J. Soderstrom · New Haven, CTDirectorJosh Harris · New York, NYDirectorMichael True · Miami, FLDirectorHolden H. Thorp · St. Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗